Discontinued — last reported Q2 '24
Procter & Gamble Corporate — Cost incurred remained flat by 0.0% to $92.75M in Q2 2024 compared to the prior quarter. Year-over-year, this metric grew by 130.4%, from $40.25M to $92.75M. Over 3 years (FY 2021 to FY 2024), Corporate — Cost incurred shows an upward trend with a 25.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates rising administrative or overhead burdens, while a decrease signals successful cost-cutting initiatives or improved operational efficiency at the corporate level.
This represents the aggregate operating costs and expenses attributed to the corporate segment that are not directly tie...
Comparable to 'Corporate SG&A' or 'Unallocated Corporate Expenses' in other multinational corporations, representing the cost of central management.
pg_segment_corporate_cost_incurred| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $190.00M | $71.00M | $161.00M | $371.00M |
| YoY Change | — | -62.6% | +126.8% | +130.4% |